Low Dose Prednisone Therapy in Women With Recurrent Pregnancy Loss
NCT04558268 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 242
Last updated 2020-09-22
Summary
For many years there is a lack of large randomized controlled trials that study the effect of low dose prednisone in women with RPL and thus the evidence of a probable efficacy of prednisone in RPL women remains limited and unclear. As the ESHRE recommended in 2018 (2) we aim to assess the effect of such treatment in a large trial that includes unexplained and abnormal autoimmune profile RPL patients. we also aim to assess the side effects of the treatment in RPL pregnant women.
Conditions
- Recurrent Pregnancy Loss(RPL)
- Recurrent Miscarriage
Interventions
- DRUG
-
Prednisone is a corticosteroid. It prevents the release of substances in the body that cause inflammation. It also suppresses the immune system. Prednisone is used as an anti-inflammatory or an immunosuppressant medication. Prednisone treats many different conditions such as allergic disorders, skin conditions, ulcerative colitis, arthritis, lupus, psoriasis, or breathing disorders.
- DRUG
-
Progesterone
Progesterone is a female hormone important for the regulation of ovulation and menstruation. Progesterone is used to cause menstrual periods in women who have not yet reached menopause but are not having periods due to a lack of progesterone in the body. It is also used to prevent overgrowth in the lining of the uterus in postmenopausal women who are receiving estrogen hormone replacement therapy.
- DIETARY_SUPPLEMENT
-
vit D
Vitamin D acts on our bones, intestines, kidneys and parathyroid glands to keep calcium in balance throughout our body. Vitamin D receptors are also located within our cardiovascular system, lungs, pancreas, skeletal muscle, skin, and reproductive organs. In summary, vitamin D is a prohormone that is essential for good health.
- DIETARY_SUPPLEMENT
-
Iron Supplement
Iron is one of the minerals in the human body. It is one of the components of hemoglobin, the substance in red blood cells that helps blood carry oxygen throughout the body.
- DIETARY_SUPPLEMENT
-
Folic Acid
Folic acid is a type of B vitamin that is normally found in foods such as dried beans, peas, lentils, oranges, whole-wheat products, liver, asparagus, beets, broccoli, brussels sprouts, and spinach. Folic acid helps your body produce and maintain new cells, and also helps prevent changes to DNA that may lead to cancer.
Sponsors & Collaborators
-
Soroka University Medical Center
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 25 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-12-31
- Primary Completion
- 2021-07-31
- Completion
- 2021-10-31
Countries
- Israel
Study Locations
More Related Trials
-
Progesterone for First Trimester Vaginal Bleeding
NCT01501890 ·Status: WITHDRAWN ·Phase: NA
-
Preconceptional Thromboprophylaxis in Recurrent PREGNANCY LOSSES Caused by Antiphospholipid Syndrome
NCT01661439 ·Status: UNKNOWN
-
Genomics and Microbiome Investigation in Cases of Recurrent Pregnancy Losses
NCT06604338 ·Status: RECRUITING
-
Effect of Low Molecular Heparin on Pregnancy Outcome With Protein S Deficiency
NCT06531525 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
The Role of Prothrombin Gene and Methylenetetrahydrofolate Reductase(MTHFR) Gene Polymorphisms as Risk Factors for Recurrent Miscarriage
NCT03209063 ·Status: UNKNOWN
-
Improving Aspirin Prescription Rates in Outpatient Clinic
NCT06694233 ·Status: TERMINATED
-
On Pregnancy After Losses - OPAL Study
NCT05167812 ·Status: NOT_YET_RECRUITING
-
AntiPhospholipid Syndrome Low-molecular-weight Heparin Pregnancy Loss Evaluation: The Pilot Study
NCT03100123 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Losartan for Improved Vascular Endothelial Function After Preeclampsia
NCT04632589 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
An Randomized Double Blind Controlled Trial of niPGT-A in Women With RPL
NCT05685147 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Steroids and Antiphospholipid Syndrome- Related Pregnancy Loss
NCT00180778 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Liposomal Iron 30 mg Supplement in Non-anemic Pregnant Females
NCT06669052 ·Status: NOT_YET_RECRUITING
-
Effect of Hydroxytyrosol on NLR, MLR, and SOD in Hypertensive Pregnant Women
NCT07074548 ·Status: COMPLETED ·Phase: NA
-
Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss
NCT03305263 ·Status: UNKNOWN ·Phase: PHASE3
-
Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss
NCT02379650 ·Status: WITHDRAWN ·Phase: PHASE2
-
Maternal and Newborn Safety Profile of Progestogens in EARLY Pregnancy
NCT05186779 ·Status: TERMINATED
-
Repeat Antenatal Corticosteroids
NCT03133104 ·Status: COMPLETED
-
Praluent® (Alirocumab) Pregnancy Exposure Registry: An OTIS Pregnancy Surveillance Study
NCT03379558 ·Status: TERMINATED
-
Progesterone for the Prevention of Miscarriage and Preterm Birth in Women With First Trimester Bleeding: PREEMPT Trial
NCT02145767 ·Status: COMPLETED ·Phase: PHASE2
-
RPL: Interval to Live Birth and Adverse Perinatal Outcomes
NCT04360564 ·Status: UNKNOWN
-
The Effectiveness of Aspirin on Preventing Pre-eclampsia
NCT04656665 ·Status: UNKNOWN ·Phase: PHASE4
-
Prenatal Test for Fetal Aneuploidy Detection
NCT01256606 ·Status: COMPLETED
-
Live Birth Rate in Patients With Unexplained Recurrent Pregnancy Loss
NCT04621773 ·Status: UNKNOWN
-
Treatment With Aspirin After Preeclampsia: TAP Trial
NCT06281665 ·Status: RECRUITING ·Phase: PHASE4
-
A Follow-up of the Early Pregnancy Study Cohort.
NCT01132924 ·Status: COMPLETED